• Issue

    Catheterization and Cardiovascular Interventions: Volume 97, Issue 5

    i-ix, 755-961, E607-E747
    April 1, 2021
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION - COPYRIGHT

Free Access

Issue Information - Copyright

  • Page: i
  • First Published: 14 April 2021

ISSUE INFORMATION - EDITORIAL BOARD

Free Access

Issue Information - Editorial Board

  • Page: ii
  • First Published: 14 April 2021

ISSUE INFORMATION - TOC

Free Access

Issue Information - TOC

  • Pages: iv-ix
  • First Published: 14 April 2021

CORONARY ARTERY DISEASE

ORIGINAL STUDIES

Percutaneous coronary intervention of unprotected left main and bifurcation in octogenarians: Subanalysis from RAIN (veRy thin stents for patients with left mAIn or bifurcatioN in real life)

Federico Conrotto MD,  Fabrizio D'Ascenzo MD,  Francesco Piroli MD,  Alfonso Franzé MD,  Leonardo de Luca MD,  Giorgio Quadri MD,  Nicola Ryan MD,  Javier Escaned MD,  Mario Bo MD,  Gaetano Maria De Ferrari MD, 
  • Pages: 755-763
  • First Published: 01 June 2020

EDITORIAL COMMENT

We can, but should we?

Nachiket J. Patel MD, FACC, FSCAI,  Samuel M. Butman MD, FACC, FSCAI, 
  • Pages: 764-765
  • First Published: 14 April 2021
Key Points

  • Octogenarians can and do undergo successful coronary interventions.
  • Complexity, calcification, and more diffuse disease are more common in this group.
  • Randomized trials of medical and/or surgical and/or percutaneous approaches in octogenarians are needed.

ORIGINAL STUDIES

Antithrombotic regimens for percutaneous coronary intervention of the left main coronary artery: The EXCEL trial

Sorin J. Brener MD,  Nicholas J. Lembo MD,  David E. Kandzari MD,  Manel Sabaté MD, PhD,  Anthony H. Gershlick MD,  Adrian P. Banning MD,  Paweł E. Buszman MD, PhD,  Ioanna Kosmidou MD, PhD,  Charles A. Simonton MD,  Marie-Claude Morice MD,  Ori Ben-Yehuda MD,  Ovidiu Dressler MD,  Zixuan Zhang MS,  Joseph F. Sabik III MD,  Arie Pieter Kappetein MD, PhD,  Patrick W. Serruys MD, PhD,  Gregg W. Stone MD, 
  • Pages: 766-773
  • First Published: 17 March 2020

EDITORIAL COMMENT

Bivalirudin versus heparin in PCI: Is the pendulum swinging again in favor of heparin?

Johny Nicolas MD,  Roxana Mehran MD, 
  • Pages: 774-775
  • First Published: 14 April 2021
Key Points

  • The optimal antithrombotic strategy in patients with left main disease (LMD) and undergoing percutaneous coronary intervention (PCI) remains unknown due to the underrepresentation of these high-risk patients in clinical trials.
  • Bivalirudin does not seem to offer any additional benefits when compared with heparin, even in high-risk patients such as those with LMD.
  • Additional randomized clinical trials are needed to establish the optimal antithrombotic therapy regimen among LMD patients undergoing PCI.

ORIGINAL STUDIES

Comparison of simple versus complex stenting in patients with true distal left main bifurcation lesions

Cheol Hyun Lee MD,  Jung-Min Ahn MD,  Do-Yoon Kang MD,  Minkyu Han PhD,  Hanbit Park MD,  Pil Hyung Lee MD,  Seung-Whan Lee MD,  Seong-Wook Park MD,  Duk-Woo Park MD,  Seung-Jung Park MD, 
  • Pages: 776-785
  • First Published: 08 September 2020

EDITORIAL COMMENT

PCI for left main bifurcation stenting: A treatment paradigm at a crossroads?

Hoshang Farhad MD,  Michael S. Levy MD, MPH, 
  • Pages: 786-787
  • First Published: 14 April 2021
Key Points

  • Percutaneous Coronary Intervention (PCI) with Drug-eluting stents (DES) for significant left main (LM) disease is an accepted therapeutic alternative to coronary artery bypass grafting (CABG) in appropriate patients based on SYNTAX II score stratification.
  • Conflicting outcome data regarding use of single versus dual-stent strategies for LM disease exist.
  • Further prospective randomized data using current generation DES and contemporary PCI techniques will provide more insight into optimal treatment strategies.

ORIGINAL STUDIES

A meta-analysis of efficacy and safety of genotype-guided versus standard of care treatment strategies in selecting antiplatelet therapy in patients with acute coronary syndrome

Salik Nazir MD,  Keerat R. Ahuja MD,  Hafeez U. H. Virk MD,  Ahmed Elzanaty MD,  Tayyab A. Waheed MD,  Khalid H. Changal MD,  Kevin Wohlfarth PharmD,  Vladimir Lakhter DO,  Robert D. Grande MD,  Ehab A. Eltahawy MD, MPH, 
  • Pages: 788-794
  • First Published: 03 April 2020

EDITORIAL COMMENT

Genotype-guided antiplatelet therapy for acute coronary syndrome percutaneous coronary intervention patients: A new standard of care?

Kellan E. Ashley MD,  William B. Hillegass MD, PhD, 
  • Pages: 795-796
  • First Published: 14 April 2021
Key Points

  • In acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention, ischemic and bleeding outcomes at 1 year can be meaningfully improved with genotype-guided antiplatelet therapy (GGT).
  • At the population level, GGT appears cost-effective and perhaps cost-saving in ST-elevation myocardial infarction patients only when initiated during the index ACS hospitalization.
  • At the individual patient level, practical clinical and economic factors undercut the feasibility of GGT becoming a new standard of care.

ORIGINAL STUDIES

Sex differences in 1-year clinical outcomes after percutaneous coronary intervention with COMBO stents: From the COMBO collaboration

Jaya Chandrasekhar MBBS, MS,  Laura S. Kerkmeijer MD,  Deborah N. Kalkman MD, PhD,  Samantha Sartori PhD,  Melissa B. Aquino MS,  Pier Woudstra MD, PhD,  Marcel A. Beijk MD, PhD,  Jan G. Tijssen PhD,  Karel T. Koch MD, PhD,  Petr Hájek MD, PhD,  Borislav Atzev MD, PhD,  Martin Hudec MD,  Tiong K. Ong MD,  Martin Mates MD,  Borislav Borisov MD,  Hazem M. Warda MD,  Peter den Heijer MD, PhD,  Jaroslaw Wojcik MD,  Andres Iñiguez MD, PhD,  Zdeněk Coufal MD,  Ahmed Khashaba MD,  Muhammad Munawar MD,  Robert T. Gerber MD,  Bryan P. Yan MD,  Michael Lee MD,  Usman Baber MD, MS,  George D. Dangas MD, PhD,  Antonio Colombo MD,  Robbert J. de Winter MD, PhD,  Roxana Mehran MD, On behalf of the MASCOT and REMEDEE investigators (full list of collaborators shown in the Appendix) , 
  • Pages: 797-804
  • First Published: 21 March 2020

EDITORIAL COMMENT

New generation drug eluting stents: Closing the gap in sex disparity in cardiovascular outcomes in women

Odayme Quesada MD,  Timothy D. Henry MD, 
  • Pages: 805-806
  • First Published: 14 April 2021
Key Points

  • Use of the novel COMBO stent, circumferentially coated with anti-CD34 antibodies to promote endothelialization and decrease inflammation led to extremely low 1-year event rates with no sex differences .
  • Technological advances in new generation drug-eluting stents has closed the gap in sex disparities for cardiovascular outcomes.
  • Women continue to be underrepresented in clinical trials and there is room to improve procedure related aspects such as radial access and potent antiplatelet therapy.

ORIGINAL STUDIES

Quantitative flow ratio—Meta-analysis and systematic review

Carlos Cortés MD, PhD,  Manuel Carrasco-Moraleja Msc,  Alvaro Aparisi MD,  Tania Rodriguez-Gabella MD,  Alberto Campo MD,  Hipolito Gutiérrez MD,  Fabián Julca MD,  Itziar Gómez Msc,  Jose Alberto San Román MD, PhD,  Ignacio J. Amat-Santos MD, PhD, 
  • Pages: 807-814
  • First Published: 20 March 2020

Coronary artery disease management and cost implications with fractional flow reserve guided coronary intervention in Indian patients with stable ischemic coronary artery disease

Viji S. Thomson MD, DM,  Mithun J. Varghese MD, DM,  Sujith T. Chacko MD, DM,  Lijo Varghese MD, DM,  Anoop G. Alex MD, DM,  Paul V. George MD, DM,  Oommen K. George MD, DM,  George Joseph MD, DM,  Bijesh K. Yadav MSc. Biostatistics,  Jacob John MD Community Medicine, 
  • Pages: 815-824
  • First Published: 15 April 2020

Resting distal to aortic pressure ratio and fractional flow reserve discordance affects the diagnostic performance of quantitative flow ratio: Results from an individual patient data meta-analysis

Jelmer Westra MD,  Ashkan Eftekhari MD, PhD,  Shengxian Tu PhD,  Gianluca Campo MD,  Javier Escaned MD, PhD,  Simon Winther MD, PhD,  Hitoshi Matsuo MD, PhD,  Xinkai Qu MD,  Lukasz Koltowski MD, PhD,  Yunxiao Chang MSc,  Tommy Liu MD,  Junqing Yang MD,  Birgitte Krogsgaard Andersen BSc,  William Wijns MD, PhD,  Morten Böttcher MD, PhD,  Evald Høj Christiansen MD, PhD,  Bo Xu MBBS,  Niels Ramsing Holm MD, 
  • Pages: 825-832
  • First Published: 01 June 2020

EDITORIAL COMMENT

QFR accuracy and Pd/pa:FFR discordance: Too much inside baseball or novel physiologic insight?

Arnold H. Seto MD, MPA, FSCAI, FACC,  Morton J. Kern MD, MSCAI, FACC, FAHA, 
  • Pages: 833-835
  • First Published: 14 April 2021
Key Points

  • The accuracy of angiographic fractional flow reserve (FFR) compared with wire-based FFR remains suboptimal.
  • This patient-level meta-analysis demonstrates that discordance between Pd/Pa and FFR is associated with QFR discordance
  • Limits to the predictability of FFR include variation in myocardial resistance, myocardial mass, and adenosine responses.

CASE REPORTS

The absence of evidence is not the evidence of absence: A case report on the challenges in diagnosing ostial left main stenosis

Ayesha Shaik MD,  Wassim Mosleh MD,  Khagendra Dahal MD,  Christopher Pickett MD,  Michael Azrin MD, 
  • Pages: 836-840
  • First Published: 20 August 2020

Three-year outcome with drug-coated balloon percutaneous coronary intervention in coronary Takayasu arteritis: A case review

Kayla L. X. Chiew BSc, MBBS,  Pitt O. Lim MD, FRCP, FESC, FSCAI, 
  • Pages: 841-846
  • First Published: 04 July 2020

CORE CURRICULUM

Adapting STEMI care for the COVID-19 pandemic: The case for low-risk STEMI triage and early discharge

John J. Lopez MD, FACC,  Joseph E. Ebinger MD, MS, FACC,  Sorcha Allen MD,  Mehmet Yildiz MD,  Timothy D. Henry MD, FACC, MSCAI, 
  • Pages: 847-849
  • First Published: 01 June 2020

EDITORIAL

Lessons learned from reduced acute cardiovascular events and STEMI during Covid-19

Samin K. Sharma MD,  Valentin Fuster MD, PhD,  Leonard Hofstra MD, PhD,  Annapoorna S. Kini MD,  Arthur Gianelli MBA,  Jagat Narula MD, PhD, 
  • Pages: 850-852
  • First Published: 03 September 2020

INTERVENTIONAL PERSPECTIVE

Training in high-risk coronary procedures and interventions: Recommendations for core competencies

Rhian E. Davies DO, MS,  Megha Prasad MD, MS,  Khaldoon Alaswad MD,  Robert F. Riley MD, MS,  Perwaiz Meraj MD,  Craig Thompson MD,  Arasi Maran MD,  Dimitri Karmpaliotis MD,  James M. McCabe MD,  Ajay J. Kirtane MD, SM,  William L. Lombardi MD, 
  • Pages: 853-858
  • First Published: 11 September 2020

PEDIATRIC AND CONGENITAL HEART DISEASE

ORIGINAL STUDIES

Feasibility of transcatheter closure for absent aortic rim in patients with atrial septal defect

Yoichi Takaya MD,  Teiji Akagi MD,  Koji Nakagawa MD,  Rie Nakayama MD,  Takashi Miki MD,  Norihisa Toh MD,  Hiroshi Ito MD, 
  • Pages: 859-864
  • First Published: 18 January 2021

CASE REPORT

Modified wire atrial septostomy with a reverse transseptal puncture in an infant: Case report

Yusaku Nagatomo MD, PhD,  Hazumu Nagata MD, PhD,  Kenichiro Yamamura MD, PhD, MSc,  Shouichi Ohga MD, PhD, 
  • Pages: 865-868
  • First Published: 04 February 2021

PERIPHERAL VASCULAR DISEASE

CASE REPORT

Catheter directed embolectomy of right atrial clot in transit-A case series

Isha Verma MD,  Eric Y Chang MD,  Gautam Kumar MD,  Rajesh Sachdeva MD, 
  • Pages: 869-873
  • First Published: 23 November 2020

POINT-COUNTERPOINT

Expanding the stroke team to include interventional cardiology

Farrell O. Mendelsohn MD,  David R. Holmes Jr MD,  L. Nelson Hopkins MD, 
  • Pages: 874-875
  • First Published: 22 October 2020

VALVULAR AND STRUCTURAL HEART DISEASES

ORIGINAL STUDIES

Four-year mortality in women and men after transfemoral transcatheter aortic valve implantation using the SAPIEN 3

Giuseppe Tarantini MD, PhD, FESC,  Helmut Baumgartner MD, FESC,  Derk Frank MD,  Oliver Husser MD, PhD,  Sabine Bleiziffer MD, PhD,  Tanja Rudolph MD, PhD,  Raban Jeger MD,  Chiara Fraccaro MD, PhD,  Tomas Hovorka MSc,  Olaf Wendler MD, PhD, 
  • Pages: 876-884
  • First Published: 04 September 2020

Sex-stratified analysis of the safety of percutaneous left atrial appendage occlusion

Mohammed Osman MD,  Brijesh Patel DO,  Muhammad Bilal Munir MD,  Akram Kawsara MD,  Babikir Kheiri MD MSc,  Sudarshan Balla MD,  Ramesh Daggubati MD,  Erin D. Michos MD MHS,  Mohamad Alkhouli MD, 
  • Pages: 885-892
  • First Published: 13 October 2020

EDITORIAL COMMENT

Gender and left atrial appendage occlusion: Not the exception in cardiovascular procedures

Jorge A. Belardi MD, FSCAI, FACC,  Pablo M. Lamelas MD, MSc, 
  • Pages: 893-894
  • First Published: 14 April 2021
Key Points

  • Gender disparities have been described in many cardiovascular procedures, but reports about left atrial appendage occlusion are limited.
  • In a large national database, women were associated with lower utilization and worse clinical results.
  • There is a need to better understand the root of the observed gender disparities and interventions to reverse it.

ORIGINAL STUDIES

Effect of a fourth-generation transcatheter valve enhanced skirt on paravalvular leak

Garrett A. Welle MD,  Bassim El-Sabawi MD,  Jeremy J. Thaden MD,  Kevin L. Greason MD,  Kyle W. Klarich MD,  Vuyisile T. Nkomo MD, MPH,  Mohamad A. Alkhouli MD,  Mayra E. Guerrero MD,  Juan A. Crestanello MD,  David R. Holmes Jr MD,  Charanjit S. Rihal MD, MBA,  Mackram F. Eleid MD, 
  • Pages: 895-902
  • First Published: 06 October 2020

EDITORIAL COMMENT

Paravalvular leak after TAVR: remarkable improvement but not the time to shift focus

Dhruv Mahtta DO, MBA,  Hani Jneid MD, 
  • Pages: 903-904
  • First Published: 14 April 2021
Key Points

  • Significant paravalvular leak (PVL) among patients undergoing transcatheter aortic valve replacement (TAVR) portends a poor prognosis and is often associated with increased mortality.
  • TAVR with the latest generation balloon-expandable valve platform, Edwards SAPIEN 3 Ultra, is associated with lower incidence of PVL (including lower rates of mild PVL and zero incidence of moderate and severe PVL) compared to its predecessor, the SAPIEN 3 valve platform.
  • The similar safety profile, comparable deliverability, and lower PVL observed with the Edwards SAPIEN 3 Ultra system will likely lead to its increased adoption in clinical practice. Future studies are needed to examine its long-term clinical outcomes and further decipher the procedural and patient factors associated with PVL.

ORIGINAL STUDIES

A novel technique for postclosure of large-bore sheaths using two Perclose devices

Charles H. Choi MD,  James Kevin Hall MD,  Diego Malaver MSA,  Robert J. Applegate MD,  David X. M. Zhao MD, FACC, FSCAI, 
  • Pages: 905-909
  • First Published: 24 October 2020

PERIPHERAL VASCULAR DISEASE

EDITORIAL COMMENT

Reducing vascular complications of large-bore sheaths removal with a novel post-closure technique: Adapt and evolve

Giuseppe Tarantini MD, PhD,  Luca Nai Fovino MD, PhD, 
  • Pages: 910-911
  • First Published: 14 April 2021
Key Points

  • Vascular complications after structural heart intervention and use of percutaneous mechanical circulatory support predominantly result from vascular closure device failure.
  • This study showed the safety and feasibility of a novel “post-closing” technique using two Perclose Proglides, based on proximation of the large-size arteriotomy by pushing two stiff guidewires apart.
  • Future randomized studies should compare this novel suture-based vascular closure technique with plug-based vascular closure devices, such as MANTA.

VALVULAR AND STRUCTURAL HEART DISEASES

ORIGINAL STUDIES

Effectiveness and safety of same day discharge after left atrial appendage closure under moderate conscious sedation

Konstantinos Marmagkiolis MD,  Ismail Ates MD,  Gulcan Kose MD,  Cezar Iliescu MD,  Mehmet Cilingiroglu MD, 
  • Pages: 912-916
  • First Published: 16 November 2020

EDITORIAL COMMENT

Left atrial appendage closure: Moving toward a same day standard

Aaron V. Kaplan MD, FACC, FSCAI, FNAI, 
  • Pages: 917-918
  • First Published: 14 April 2021
Key Points

  • Multicenter study showing the ability to perform TEE guided left atrial appendage occlusion using conscious sedation with same day discharge in selected patients
  • This study along with others highlight the need to move left atrial appendage closure to a conscious procedure
  • Further studies will be needed to prospectively validate selection criteria and the protocol used by the investigators

ORIGINAL STUDIES

Impact of preexisting coronary arterial disease in patients undergoing percutaneous mitral valve repair (MitraClip)

Kristina Gifft DO,  Jad Omran MD,  Fadi Ghrair MD,  Haytham Allaham MD,  Mohammad Eniezat MS,  Obai Abdullah MD,  Tariq Enezate MD, 
  • Pages: 919-924
  • First Published: 28 November 2020

EDITORIAL COMMENT

Coronary arterial disease in patients undergoing percutaneous edge-to-edge mitral valve repair: Handle with care

Giuseppe Musumeci MD,  Marzia Colopi MD, 
  • Pages: 925-926
  • First Published: 14 April 2021
Key Points

  • Percutaneous mitral valve repair using the MitraClip System is a revolutionary treatment option for patients with severe mitral regurgitation (MR) and prohibitive surgical risk.
  • Coronary arterial disease is a frequent comorbidity in patients with severe MR.
  • The impact of concomitant coronary artery disease and revascularization on outcome in patients undergoing transcatheter mitral valve repair is still an ongoing debate.

ORIGINAL STUDIES

Consequences of canceling elective invasive cardiac procedures during Covid-19 outbreak

Raúl Moreno MD, PhD,  José-Luis Díez MD,  José-Antonio Diarte MD,  Fernando Macaya MD,  José-María de la Torrre Hernández MD, PhD,  Oriol Rodríguez-Leor MD,  Ramiro Trillo MD,  Juan Alonso-Briales MD, PhD,  Ignacio Amat-Santos MD,  Rafael Romaguera MD,  José-Francisco Díaz MD,  Beatriz Vaquerizo MD, PhD,  Soledad Ojeda MD,  Ignacio Cruz-González MD, PhD,  Daniel Morena-Salas MD,  Armando Pérez de Prado MD, PhD,  Fernando Sarnago MD,  Pilar Portero MD, PhD,  Alejandro Gutierrez-Barrios MD, PhD,  Fernando Alfonso MD, PhD,  Eduard Bosch MD,  Eduardo Pinar MD,  José-Ramón Ruiz-Arroyo MD,  Valeriano Ruiz-Quevedo MD,  Jesús Jiménez-Mazuecos MD,  Fernando Lozano MD, PhD,  José-Ramón Rumoroso MD,  Enrique Novo MD,  Francisco J Irazusta MD,  Bruno García del Blanco MD,  José Moreu MD, PhD,  Sara M Ballesteros-Pradas MD,  Araceli Frutos MD,  Manuel Villa MD,  Eduardo Alegría-Barrero MD, PhD,  Rosa Lázaro MD,  Emilio Paredes MD, 
  • Pages: 927-937
  • First Published: 17 December 2020

CORONARY ARTERY DISEASE

EDITORIAL COMMENT

Postponing cardiac procedures during the pandemic: The balance between elective and selective!

Stefano Garzon MD,  Pedro A. Lemos MD, PhD, 
  • Pages: 938-939
  • First Published: 14 April 2021
Key Points

  • What the article teaches:Postponing elective cardiac procedures may have an adverse impact on short-term outcomes.

  • How it will impact practice:Elective patients scheduled for cardiac procedures have different risk profiles and the decision for postponing should take into consideration the chances of complications related to the deferral.

  • What new research would help answer the question:Better validate tools to identify which subsets are more prone to early complications in case a scheduled invasive procedure is suspended.

VALVULAR AND STRUCTURAL HEART DISEASES

ORIGINAL STUDIES

Safety of same-day discharge after uncomplicated, minimalist transcatheter aortic valve replacement in the COVID-19 era

Emily Perdoncin MD,  Adam B. Greenbaum MD,  Kendra J. Grubb MD, MHA,  Vasilis C. Babaliaros MD,  Patricia Keegan DNP,  Brendan Ceretto-Clark MSPH,  Jane Wei MPH,  Robert A. Guyton MD,  Gaetano Paone MD,  Isida Byku MD,  Patrick T. Gleason MD,  Kelby Biven PA-C,  Preethy Mathew NP,  Cecilia Mortorano MSN,  Errol K. Inci MD,  Christian Faaborg-Andersen BS,  Rae Mitchell MSN,  Chandan M. Devireddy MD, MBA, FSCAI, 
  • Pages: 940-947
  • First Published: 31 December 2020

EDITORIAL COMMENT

Same day discharge: How much less is more for TAVR patients?

Uri Landes MD,  Ran Kornowski MD, FACC, FESC, 
  • Pages: 948-949
  • First Published: 14 April 2021
Key Points

  • In a single-center retrospective analysis, 29 same day discharge (SDD) Transcatheter aortic valve replacement (TAVR) patients were treated and no patient had died or had a stroke event or needed a new pacemaker and/or experienced readmission to hospital at 30 days.
  • SDD criteria should focus on patient characteristics and procedural factors, but also on social support, tight ambulatory follow-up, and team consensus that hospital bed is no longer required.
  • As TAVR continues to develop, we should ask ourselves: how much less is more for the TAVR patient?

CASE REPORTS

Transcatheter aortic valve implantation for severe pure aortic regurgitation due to active aortitis

Rossella Ruggiero MD,  Francesco Ponticelli MD,  Francesco Giannini MD,  Marcello Galvani MD, 
  • Pages: 950-954
  • First Published: 31 August 2020

A novel technique to manage transcatheter aortic valve embolization

Kunal K. Chawla MD,  Xiangke Huang MD,  Neal Hadro MD,  Ashequl M. Islam MD, 
  • Pages: 955-958
  • First Published: 10 October 2020

A dedicated Y-shaped percutaneous ECMO cannula for femoral 2-in-1 vascular access during high-risk procedures

Thomas Modine MD, PhD,  Flavien Vincent MD, PhD,  Cédric Delhaye MD,  Eric Van Belle MD, PhD, 
  • Pages: 959-961
  • First Published: 01 October 2020

CORONARY ARTERY DISEASE

ORIGINAL STUDIES

Two-year outcomes after percutaneous coronary intervention with drug-eluting stents or bare-metal stents in elderly patients with coronary artery disease

Alexandre Lafont MD,  Peter R Sinnaeve MD, PhD,  Thomas Cuisset MD, PhD,  Stéphane Cook MD, PhD,  Giorgios Sideris MD, PhD,  Sasko Kedev MD, PhD,  Didier Carrie MD, PhD,  Thomas Hovasse MD,  Philippe Garot MD,  Rami El Mahmoud MD,  Christian Spaulding MD,  Gérard Helft MD, PhD,  José F Diaz Fernandez MD,  Salvatore Brugaletta MD,  Eduardo Pinar-Bermudez MD,  Josepa Mauri Ferre MD,  Philippe Commeau MD,  Emmanuel Teiger MD, PhD,  Kris Bogaerts MD, PhD,  Manel Sabate MD, PhD,  Marie Claude Morice MD,  Olivier Varenne MD, PhD,  for the SENIOR investigators , 
  • Pages: E607-E613
  • First Published: 06 August 2020

Efficacy of drug-coated balloon angioplasty after directional coronary atherectomy for coronary bifurcation lesions (DCA/DCB registry)

Shunsuke Kitani MD,  Yasumi Igarashi MD, PhD,  Etsuo Tsuchikane MD, PhD,  Shigeru Nakamura MD, PhD,  Yoshitane Seino MD, PhD,  Maoto Habara MD,  Yoshihiro Takeda MD,  Kenichiro Shimoji MD, PhD,  Yoshinori Yasaka MD, PhD,  Mikihiro Kijima MD, PhD, 
  • Pages: E614-E623
  • First Published: 10 August 2020

Characteristics of cardiac catheterization laboratory directors at the 2017 U.S. News & World Report top 100 U.S. cardiovascular hospitals

Karthik Murugiah MD,  Amarnath R. Annapureddy MD,  Rohan Khera MD, MS,  Alexandra Lansky MD,  Jeptha P. Curtis MD, 
  • Pages: E624-E626
  • First Published: 24 August 2020

Gender-based outcomes of impeller pumps percutaneous ventricular assist devices

Mohammed Osman MD,  Moinuddin Syed MD,  Yasir Abdul Ghaffar MD,  Brijesh Patel DO,  Ashraf Abugroun MD,  Babikir Kheiri MD, MSc,  Akram Kawsara MD,  Madhavi Kadiyala MD,  Sudarshan Balla MD,  Ramesh Daggubati MD, 
  • Pages: E627-E635
  • First Published: 15 October 2020

Safety and efficacy of mechanical circulatory support with Impella or intra-aortic balloon pump for high-risk percutaneous coronary intervention and/or cardiogenic shock: Insights from a network meta-analysis of randomized trials

Toshiki Kuno MD, PhD, FESC, FSCAI,  Hisato Takagi MD, PhD,  Tomo Ando MD,  Masaki Kodaira MD,  Yohei Numasawa MD, PhD,  John Fox MD,  Sripal Bangalore MD, MHA, 
  • Pages: E636-E645
  • First Published: 07 September 2020

Comparing the clinical and prognostic impact of proximal versus nonproximal lesions in dominant right coronary artery ST-elevation myocardial infarction

Giuseppe Femia BSc, MBBS,  Amir Faour MBBS,  Joseph Assad MBBS,  Lokesh Sharma,  Hanan Idris MBChB,  Oliver Gibbs BSc, MBBS, MPhil,  Patrick Pender MBBS,  Dominic Leung MBBS, PhD,  Andrew Hopkins MBBS,  Rohan Rajaratnam MBBS,  Craig P Juergens MBBS, DMedSc,  Christian Mussap MBBS, PhD,  John K French MBChB, PhD,  Sidney Lo MBBS, 
  • Pages: E646-E652
  • First Published: 01 September 2020

Excimer laser coronary atherectomy during complex PCI: An analysis of 1,471 laser cases from the British Cardiovascular Intervention Society database

Majd B. Protty MD,  Hussain I. Hussain MD,  Sean Gallagher MD,  Sara Al-Raisi MD,  Omar Aldalati MD,  Vasim Farooq PhD,  Andrew S. P. Sharp PhD,  Mohaned Egred MD,  Peter O'Kane MD,  Peter Ludman MD,  Richard A. Anderson MD,  Mamas A. Mamas PhD,  Tim Kinnaird MD, 
  • Pages: E653-E660
  • First Published: 18 September 2020

CASE REPORTS

COVID-19 complicated by acute myocardial infarction with extensive thrombus burden and cardiogenic shock

Rafael Harari MD,  Sripal Bangalore MD, MHA,  Ernest Chang MD,  Binita Shah MD, MS, 
  • Pages: E661-E666
  • First Published: 19 May 2020

Massive coronary thrombosis caused primary percutaneous coronary intervention to fail in a COVID-19 patient with ST-elevation myocardial infarction

Sherif Seif MSc,  Ahmed Ayuna MD,  Abhishek Kumar MD,  John Macdonald MD, 
  • Pages: E667-E669
  • First Published: 30 May 2020

Severe coronary spasm in a COVID-19 patient

Fernando Rivero MD,  Paula Antuña MD,  Javier Cuesta MD,  Fernando Alfonso MD, PhD, 
  • Pages: E670-E672
  • First Published: 01 August 2020

Single stick access using a VA-ECMO arterial return cannula for coronary intervention in cardiogenic shock

Navin K. Kapur MD,  Colin S. Hirst MD,  Carlos D. Davila MD,  Ron Garcia MD, 
  • Pages: E673-E675
  • First Published: 25 June 2020
Open Access

Progressive growth of coronary aneurysms after bioresorbable vascular scaffold implantation: Successful treatment with OCT-guided exclusion using covered stents

Franco Fabbiocchi MD,  Giuseppe Calligaris MD,  Antonio L. Bartorelli MD, FACC, 
  • Pages: E676-E679
  • First Published: 03 August 2020

Percutaneous coronary interventions on vein graft bifurcation lesions presenting as an acute coronary syndrome

Julien Feghaly MD, MPH,  Preetham Muskula MD,  Sundeep Kumar MD,  Tarek Helmy MD, 
  • Pages: E680-E685
  • First Published: 26 August 2020

CORE CURRICULUM

Patient care protocols and personal safety measures for health care professionals in cardiac catheterization rooms during the COVID-19 outbreak in the National Institute of Cardiology

Guering Eid-Lidt MD,  Julio Iván Farjat Pasos MD, 
  • Pages: E686-E691
  • First Published: 01 June 2020

PEDIATRIC AND CONGENITAL HEART DISEASE

CASE REPORT

Expanding percutaneous treatment of mitral valve diseases: Transcatheter closure of mitral valve leaflet perforation

Juan M. Carretero Bellón MD,  Igor C. Morr MD,  Erika F. Merchan MD,  Fredy H. Prada MD, 
  • Pages: E692-E696
  • First Published: 27 January 2021

PERIPHERAL VASCULAR DISEASE

ORIGINAL STUDIES

Efficacy of the novel technique HIRANODOME in preventing distal embolization during endovascular treatment of femoropopliteal lesions

Tomoya Fukagawa MD,  Keisuke Hirano MD,  Shinsuke Mori MD,  Masahiro Yamawaki MD,  Norihiro Kobayashi MD,  Masakazu Tsutsumi MD,  Yohsuke Honda MD,  Kenji Makino MD,  Yoshiaki Ito MD, 
  • Pages: E697-E703
  • First Published: 23 January 2021

VALVULAR AND STRUCTURAL HEART DISEASES

ORIGINAL STUDIES

Preprocedural anemia in females undergoing transcatheter aortic valve implantation: Insights from the WIN-TAVI registry

Johny Nicolas MD,  Bimmer E. Claessen MD, PhD,  Davide Cao MD,  Samantha Sartori PhD,  Usman Baber MD, MS,  David Power MD,  Mauro Chiarito MD,  Ridhima Goel MD,  Anastasios Roumeliotis MD,  Rishi Chandiramani MD,  Siyan Chen BS,  Jaya Chandrasekhar MBBS, MS,  Didier Tchetche MD,  Anna Sonia Petronio MD,  Julinda Mehilli MD,  Thierry Lefèvre MD,  Patrizia Presbitero MD,  Piera Capranzano MD,  Alessandro Iadanza MD,  Gennaro Sardella MD,  Nicolas M Van Mieghem MD PhD,  Emanuele Meliga MD,  Nicolas Dumonteil MD,  Chiara Fraccaro MD PhD,  Daniela Trabattoni MD,  Ghada Mikhail MD,  Maria-Cruz Ferrer-Gracia MD,  Christoph Naber MD,  Samin Sharma MD,  Marie-Claude Morice MD,  George D. Dangas MD PhD,  Alaide Chieffo MD,  Roxana Mehran MD, 
  • Pages: E704-E715
  • First Published: 01 October 2020

CASE REPORTS

Open Access

Early restenosis of a direct flow transcatheter aortic valve prosthesis

Verena Veulemans MD,  Amin Polzin MD,  Kerstin Piayda MD,  Tobias Zeus MD, 
  • Pages: E716-E718
  • First Published: 24 February 2020

Novel use of fused cardiac computed tomography and transesophageal echocardiography for left atrial appendage closure

Andrew Peters MD,  Afaq Motiwala MD,  Brian O'Neill MD,  Pravin Patil MD, 
  • Pages: E719-E723
  • First Published: 09 March 2020

Tangled wire in a Dacron band during Cardioband transcatheter tricuspid annuloplasty—How to solve the problem

Mizuki Miura MD, PhD,  Luca Vicentini Eng,  Maurizio Taramasso MD, PhD,  Francesco Maisano MD, 
  • Pages: E724-E726
  • First Published: 10 March 2020

Transcatheter edge-to-edge mitral valve repair for annuloplasty ring dehiscence: The peri-ring approach

Diana Otero MD,  Munis Raza MD,  Tanvir Kahlon MD,  Vikas Singh MD, 
  • Pages: E727-E730
  • First Published: 21 May 2020

Hybrid approach to postmyocardial infarction ventricular septal defect repair

Ali A. Alsaad MD,  Hyde M. Russell MD,  Arthur J. Tokarczyk MD,  Mark J. Ricciardi MD, 
  • Pages: E731-E735
  • First Published: 30 May 2020

Spontaneous thrombosis of a transcatheter aortic valve replacement-induced aortic root pseudoaneurysm

Giulia Costa MD,  Nikolaj Ihlemann MD, PhD,  Lars Søndergaard MD, DMSc,  Ole De Backer MD, PhD, 
  • Pages: E736-E738
  • First Published: 04 July 2020

Transcatheter tricuspid valve replacement in dehisced flexible ring

Daniel Maoz-Metzl MD,  Fenton H. McCarthy MD,  Daniel G. Berson DO,  Geoffrey A. Kunz MD, 
  • Pages: E739-E742
  • First Published: 06 August 2020

Snuffbox approach for balloon aortic valvuloplasty: A case series

Annamaria Di Cesare MD,  Elisabetta Tonet MD,  Gianluca Campo MD,  Carlo Tumscitz MD, 
  • Pages: E743-E747
  • First Published: 13 August 2020